Valuation: Beroni Group Limited

Capitalization 336K 240K 207K 189K 179K 330K 23.21M 2.24M 877K 10.96M 902K 883K 38.16M P/E ratio 2024
-2.72x
P/E ratio 2025 -0.07x
Enterprise value 1.71M 1.22M 1.05M 963K 910K 1.68M 118M 11.41M 4.47M 55.77M 4.59M 4.49M 194M EV / Sales 2024
109x
EV / Sales 2025 2.68x
Free-Float
21.57%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.0064
0.01
3 years 0.01
Extreme 0.0064
9.88
5 years 0.01
Extreme 0.0064
17.2
10 years 0.01
Extreme 0.0064
17.2
Manager TitleAgeSince
Chief Executive Officer 57 17/06/2016
Director of Finance/CFO 64 02/07/2018
Corporate Secretary 47 01/03/2021
Director TitleAgeSince
Director/Board Member 47 01/03/2021
Director/Board Member 68 01/07/2020
Director/Board Member 64 30/09/2016
Change 5d. change 1-year change 3-years change Capi.($)
-36.63%-.--%-36.63%-99.93% 218K
+0.81%+0.31%+36.39%+130.32% 909B
-0.47%-0.48%+49.24%+44.31% 552B
-0.26%+1.82%+14.85%+46.30% 375B
-0.15%+2.53%+24.56%+13.82% 332B
-0.54%+0.87%+32.10%+15.15% 291B
+0.17%+1.75%+26.62%+30.12% 287B
-0.23%-0.40%+44.93%-2.16% 279B
-0.99%+0.10%-37.30%-51.47% 199B
-0.01%-1.45%+20.57%+48.41% 179B
Average -3.88%+0.67%+17.53%+17.49% 340.31B
Weighted average by Cap. -0.07%+1.03%+29.32%+51.63%

Financials

2024 2025
Net sales 317K 227K 195K 179K 169K 312K 21.91M 2.12M 828K 10.34M 851K 833K 36.03M 638K 457K 393K 360K 340K 628K 44.15M 4.27M 1.67M 20.84M 1.72M 1.68M 72.59M
Net income -10.61M -7.6M -6.53M -5.98M -5.65M -10.44M -734M -70.88M -27.74M -346M -28.5M -27.9M -1.21B -4.22M -3.02M -2.6M -2.38M -2.25M -4.16M -292M -28.22M -11.04M -138M -11.35M -11.11M -480M
Net Debt -254K -182K -157K -143K -136K -250K -17.6M -1.7M -665K -8.31M -684K -669K -28.94M 1.37M 983K 845K 774K 731K 1.35M 94.93M 9.17M 3.59M 44.81M 3.69M 3.61M 156M
Logo Beroni Group Limited
Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is focused on biomedicine, artificial intelligence, and modern technology research and development. Its businesses include cell therapies, developing new anti-cancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and the detection and diagnosis of infectious diseases. Its technology includes Brain Wave Extraction patent technology, a foundational technology in the Brain-Computer Interface (BCI) field, that enables the acquisition of high-resolution electroencephalogram (EEG) signals using a minimal number of electrodes, significantly enhancing the practicality and portability of BCI systems. Its product offering includes NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, and others.
Employees
-
  1. Stock Market
  2. Equities
  3. BNIG.F Stock